| Name | Title | Contact Details |
|---|
HB Group is a Fairfield, TX-based company in the Business Services sector.
Smith Filter Corp is a Moline, IL-based company in the Business Services sector.
LifeF/X is a Newton Upper Falls, MA-based company in the Business Services sector.
As an adult, child, and adolescent psychiatrist I evaluate and treat patients of all ages with serious (and sometimes not so serious) mental health problems on a daily basis. Many of these patients have previously suffered serious consequences following a misdiagnosis, such as being prescribed the wrong type of medication or receiving improper psychotherapy. Since I am also a forensic psychiatrist, I am often the person called upon by the Court to explain how a diagnosis was missed or a treatment plan failed. I founded 360 Mental Health Services in order to offer parents, caregivers and families a highly sophisticated level of diagnostic services that I viewed as lacking in the community. I have a passion for what I do professionally, one that I hope shows not only in my video but in my interactions with patients, families, and those involved in the legal process. -Dr. Tim
InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.